4Filing Date: Sep 11, 2026
Edwards Lifesciences (EW)
Statement of Changes in Beneficial Ownership
View SEC Filing
ACC: 0001225208-26-007775
Total Value$34.5K
Trades1
Insiders1
Transaction Details
Chopra Daveen
CVP, TMTT, Surgical & IHFM·Direct
Tax W/H · Dispose
Common Stock
Shares-398
Price$86.77
Total Value$34.5K
Shares Owned After43.93K
Transaction DateSep 11, 2026
Footnotes ▸
Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e).
Post-Transaction Holdings
Chopra Daveen · CVP, TMTT, Surgical & IHFM
| Security | Shares | Change |
|---|---|---|
| Common Stock | 43.93K | -398 (-0.90%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-09-11
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: Edwards Lifesciences Corp (EW)
CIK: 0001099800
--- Reporting Owner ---
Name: Chopra Daveen
CIK: 0001740963
Role: Officer (CVP, TMTT, Surgical & IHFM)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-09-11 | Code: F (Payment of exercise/tax)
Shares: -398 | Price: $86.77
Total Value: $34,534.46
Shares Owned After: 43,926 | Ownership: D (Direct)
Footnotes:
[F1] Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e).
--- Footnotes (Complete Index) ---
F1: Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e).
--- Signature ---
/s/ Linda J. Park, Attorney-in-Fact (2026-09-11)